Literature DB >> 16596458

Has the true prevalence of voiding difficulty in urogynecology patients been underestimated?

Bernard T Haylen1, Surya Krishnan, Serena Schulz, Louise Verity, Matthew Law, Jialun Zhou, John Sutherst.   

Abstract

Voiding difficulty has been relatively overlooked as a diagnosis. Previous estimates of its prevalence have generally been no more than 14% with one exception at 24%. The aim of this study is to determine the true prevalence and associations of voiding difficulty using a validated definition [urine flow rate under 10th centile of the Liverpool Nomograms and/or residual urine volume (by transvaginal ultrasound) more than 30 ml]. This study involved 592 women referred for an initial urogynecological assessment including urodynamics. Data were separated according to the presence or absence of voiding difficulty. The prevalence of voiding difficulty was 39%, far higher than previous estimates. It is the third most common urodynamic diagnosis behind urodynamic stress incontinence (USI-72%) and uterine/vaginal prolapse (61%) and ahead of the overactive bladder (13%). Voiding difficulty significantly increased in prevalence with age and increasing grades of all types of uterine/vaginal prolapse. Prolapse appeared to be the main factor in the age deterioration. Other significant positive relationships with voiding difficulty were prior hysterectomy and prior continence surgery, whilst USI and the symptom and sign of stress incontinence had significant inverse relationships.

Entities:  

Mesh:

Year:  2006        PMID: 16596458     DOI: 10.1007/s00192-006-0094-x

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  17 in total

Review 1.  The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip Van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Urology       Date:  2003-01       Impact factor: 2.649

2.  The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.

Authors:  R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith
Journal:  Am J Obstet Gynecol       Date:  1996-07       Impact factor: 8.661

3.  Transvaginal ultrasound in the assessment of bladder volumes in women. Preliminary report.

Authors:  B T Haylen; M I Frazer; J R Sutherst; C R West
Journal:  Br J Urol       Date:  1989-02

4.  Obstructed voiding in the female.

Authors:  J A Massey; P H Abrams
Journal:  Br J Urol       Date:  1988-01

5.  Urine flow rates and residual urine volumes in urogynecology patients.

Authors:  B T Haylen; M G Law; M Frazer; S Schulz
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1999

6.  The effect of a urethral catheter on the measurement of maximum urinary flow rate.

Authors:  R L Ryall; V R Marshall
Journal:  J Urol       Date:  1982-08       Impact factor: 7.450

7.  Kinetics of urinary tract infection. II. The bladder.

Authors:  F O'Grady; W R Cattell
Journal:  Br J Urol       Date:  1966-04

8.  Bladder outlet obstruction in women: definition and characteristics.

Authors:  A Groutz; J G Blaivas; D C Chaikin
Journal:  Neurourol Urodyn       Date:  2000       Impact factor: 2.696

9.  Maximum and average urine flow rates in normal male and female populations--the Liverpool nomograms.

Authors:  B T Haylen; D Ashby; J R Sutherst; M I Frazer; C R West
Journal:  Br J Urol       Date:  1989-07

10.  Fluid weight uroflowmetry in women.

Authors:  J A Fantl; P J Smith; V Schneider; W G Hurt; L J Dunn
Journal:  Am J Obstet Gynecol       Date:  1983-04-15       Impact factor: 8.661

View more
  20 in total

1.  International Continence Society 2002 terminology report: have urogynecological conditions (diagnoses) been overlooked?

Authors:  Bernard T Haylen; Naven Chetty
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-09-05

2.  Recurrent urinary tract infections in women with symptoms of pelvic floor dysfunction.

Authors:  Bernard T Haylen; Joseph Lee; Sue Husselbee; Matthew Law; Jialun Zhou
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-03-17

3.  Uroflowmetry: its current clinical utility for women.

Authors:  Bernard T Haylen; Vivian Yang; Vanessa Logan
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-04-22

4.  Female voiding dysfunction: prevalence and common associations.

Authors:  Bernard T Haylen
Journal:  Curr Urol Rep       Date:  2009-11       Impact factor: 3.092

5.  Empirical redefinition of comprehensive health and well-being in the older adults of the United States.

Authors:  Martha K McClintock; William Dale; Edward O Laumann; Linda Waite
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-16       Impact factor: 11.205

6.  Changes in voiding function after laparoscopic sacrocolpopexy for advanced pelvic organ prolapse: a cohort study of 76 cases.

Authors:  Xiao-Chen Song; Lan Zhu; Shuo Liang; Tao Xu
Journal:  Int Urogynecol J       Date:  2017-07-18       Impact factor: 2.894

7.  The effect of urethral dilatation on pressure flow studies in women with voiding dysfunction and overactive bladder.

Authors:  Maya Basu; Jonathan Duckett
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-05-15

8.  Effect of alfuzosin on female primary bladder neck obstruction.

Authors:  A Athanasopoulos; K Gyftopoulos; K Giannitsas; P Perimenis
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-11-04

9.  Does the presenting bladder volume at urodynamics have any diagnostic relevance?

Authors:  Bernard T Haylen; Vivian Yang; Vanessa Logan; Sue Husselbee; Matthew Law; Jialun Zhou
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-12-04

Review 10.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.

Authors:  Bernard T Haylen; Dirk de Ridder; Robert M Freeman; Steven E Swift; Bary Berghmans; Joseph Lee; Ash Monga; Eckhard Petri; Diaa E Rizk; Peter K Sand; Gabriel N Schaer
Journal:  Int Urogynecol J       Date:  2009-11-25       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.